Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept Biomarker Study in Rheumatoid Arthritis
NCT03882008Phase 4Completed
- Sponsor
- University of Washington
- Start
- May 2019
- Primary completion
- Jun 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of abatacept in rheumatoid arthritis (RA), sponsored by University of Washington. Started May 2019; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03882008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03882008.